Over the projection period of 2022 to 2032, sales in the global extended release drugs industry demand are anticipated to grow at a CAGR of 11%. The market for extended-release medications is currently worth US$ 48 billion. Demand for extended-release medications is predicted to increase in the upcoming years as a result of altered prescription …
Tag Archives: Extended Release Drugs Industry
Global Extended Release Drugs Industry is projected to achieve an 11% CAGR by 2032, prioritizing medication adherence according to FMI
The global extended release drugs industry size is a fast developing area with a key role to play in optimising medication adherence and patient outcomes. Extended release pharmaceuticals, sometimes referred to as sustained release or controlled release drugs, are made to release their active ingredients gradually over an extended period of time, typically 12 to …